The article offers information on the use of electronic patient-reported outcomes (ePRO) for late phase trials. It mentions that global government regulators can make decisions on patient safety and insurers can determine formulary and reimbursements using ePRO. It adds that the use of ePRO in the integration of objective readings from medical devices enables clinicians to respond and listen to patient's voice.